Home » Topics » BioWorld Science

BioWorld Science
RSS

Oncternal advances ONCT-808 toward IND filing and ONCT-534 into IND-enabling studies

March 11, 2022

STK-002 enters preclinical toxicology studies for autosomal dominant optic atrophy

March 11, 2022

Researchers suggest IL-33R modulation for controlling lung inflammation and pulmonary fibrosis

March 11, 2022

Viridian Therapeutics offers update on nonclinical pipeline

March 11, 2022

Aligos advances early-stage programs

March 11, 2022

Small Pharma eyes clinic with DMT candidate SPL-028

March 11, 2022

Osmolytes induce kidney EMT

March 11, 2022

Sunshine Lake Pharma identifies new GTPase KRAS mutant inhibitors

March 11, 2022

Betta Pharmaceuticals presents YAP1 or TAZ/TEAD interaction inhibitors

March 11, 2022

Medshine Discovery discloses new S1PR1 agonists

March 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...